Blood Tests for Early Detection of Ovarian Cancer

Use of CA125 and Complementary Biomarkers for the Early Detection of Ovarian Cancer in Low Risk Women

Recruiting N/A Interventional Study
Ovarian Cancer
No Placebo Group Every participant receives an active treatment — no one gets a placebo. Healthy Volunteers Welcome You do not need to have the condition being studied to take part.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
50 – 74
Sex
Female
Study type
Interventional
Purpose
Screening
Participants needed
8,000 (estimated)
Sponsor
M.D. Anderson Cancer Center · Other
Who this trial is looking for

This trial is looking for women aged 50 to 75 who are at low risk for ovarian cancer. Participants will take a standard blood test and may have other tests to help detect ovarian cancer early.

Are You a Good Fit for This Trial?

You may be able to join if

  • I am a woman aged 50 to 75 years old.
  • I have gone through menopause for at least 12 months.
  • I have at least one ovary.
  • I am cancer-free and have not had chemotherapy or radiation in the last 12 months.
  • I am willing to return for CA 125 blood tests every year.
  • I am willing to have a transvaginal ultrasound if needed.
  • I can provide a gynecologist or healthcare professional for follow-up care.

You may not be able to join if

  • I am younger than 50 or older than 75 at the time of enrollment.
  • I have a psychiatric or psychological condition that affects my ability to give informed consent.
  • I have had both ovaries removed.
  • I currently have another active cancer that is not ovarian.
  • I have a family history that puts me at high risk for ovarian cancer.
  • I am a known carrier of a genetic mutation linked to HNPCC/Lynch Syndrome.

Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.

Think this trial could be right for you?

Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.

Check Your Eligibility
About This Trial

The goal of this clinical research study is to find out if combining a standard blood test (CA-125) that checks for ovarian cancer with other blood tests that check for related tumor markers may be helpful in the early detection of ovarian cancer in women who are at low risk. Tumor markers are substances in the blood that may be related to ovarian cancer.

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: 1. Female, \>/= 50 years old or less than 75 years old. 2. Postmenopausal (\>/= 12 months amenorrhea). 3. Have at least one ovary. 4. Cancer-free and have not received any chemotherapy or radiation therapy for \>/=12 months prior to enrolling on this study. 5. Willingness to ret…
Contacts

Gwen H. Corrigan

713-563-1790

gcorriga@mdanderson.org

CONTACT

Study Coordinator MD Anderson

713-563-6728

CONTACT